European Neuropsychopharmacology

译名:欧洲神经精神药理学

EUROPEAN NEUROPSYCHOPHARMACOLOGY

SCIEJCR Q1中科院2区

5-10

2026

影响因子区间

135天

平台估算

投稿周期

6%

2025

中国作者发文占比

费用说明

收费

期刊简介:European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

【译文】欧洲神经精神药理学杂志是欧洲神经精神药理学学院(ECNP)的官方出版物。根据学院的任务,该杂志专注于临床和基础科学贡献,这些贡献有助于我们了解大脑功能和人类行为,并能够转化为改善治疗和增强精神病学公共卫生影响的成果。近年来,神经科学和基因组学在基本知识和可用实验技术方面取得了令人兴奋的进展。然而,这些发现的临床转化并没有那么迅速。该杂志旨在通过推广预期将对我们对精神疾病生物学基础的理解以及治疗的发展和改进产生重大影响的发现来缩小这一差距,理想情况下为预防和康复铺平道路。

出版社
Elsevier BV
语言
English
学科
医学
ISSN
0924-977X
eISSN
1873-7862
出版频率
月刊
创刊年份
1990
投稿网址
https://www.editorialmanager.com/NEUPSY
最近更新
2026-04-02 18:16:40
European Neuropsychopharmacology

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区2区
暂无
影响因子区间5-10
暂无